Wird geladen...
Third-generation epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small cell lung cancer
Mutations in the epidermal growth factor receptor (EGFR) gene are the most common targetable genomic drivers of non-small cell lung cancer (NSCLC), occurring in approximately 50% and 10–15% of adenocarcinomas of the lung in Asian and Western populations, respectively. The most common EGFR-activating...
Gespeichert in:
| Veröffentlicht in: | Transl Lung Cancer Res |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
AME Publishing Company
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6894985/ https://ncbi.nlm.nih.gov/pubmed/31857949 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr.2019.06.01 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|